Aurora Cannabis Inc. (ACB.TO)
CAD 5.81
(-5.37%)
CAD 5.81
(-5.37%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -8.64 Million CAD | 88.21% |
| 2022 | -73.32 Million CAD | 56.44% |
| 2021 | -168.31 Million CAD | -668.32% |
| 2020 | -21.9 Million CAD | -105.94% |
| 2019 | 369.06 Million CAD | -21.82% |
| 2018 | 472.09 Million CAD | 314.06% |
| 2017 | 114.01 Million CAD | 218.88% |
| 2016 | -95.9 Million CAD | -1029.63% |
| 2015 | 10.31 Million CAD | 28.09% |
| 2014 | 8.05 Million CAD | 2225.37% |
| 2013 | -378.98 Thousand CAD | 41.22% |
| 2012 | -644.71 Thousand CAD | 40.99% |
| 2011 | -1.09 Million CAD | -4994.46% |
| 2010 | -21.44 Thousand CAD | 81.66% |
| 2009 | -116.92 Thousand CAD | 92.65% |
| 2008 | -1.59 Million CAD | 2.39% |
| 2007 | -1.63 Million CAD | -280.86% |
| 2006 | -428.06 Thousand CAD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 Q1 | -1.9 Million CAD | -29.57% |
| 2023 Q2 | -41.02 Million CAD | -2052.57% |
| 2023 Q3 | -8.64 Million CAD | 78.92% |
| 2023 FY | -8.64 Million CAD | 88.21% |
| 2022 Q4 | -1.47 Million CAD | 80.18% |
| 2022 Q2 | -32.63 Million CAD | 25.35% |
| 2022 FY | -73.32 Million CAD | 56.44% |
| 2022 Q3 | -7.42 Million CAD | 77.26% |
| 2022 Q1 | -43.71 Million CAD | 74.03% |
| 2021 Q2 | 82.04 Million CAD | 141.42% |
| 2021 Q1 | 33.98 Million CAD | 255.13% |
| 2021 FY | -168.31 Million CAD | -668.32% |
| 2021 Q4 | -168.31 Million CAD | -303.13% |
| 2021 Q3 | -41.75 Million CAD | -150.89% |
| 2020 Q2 | 108.98 Million CAD | -70.81% |
| 2020 FY | -21.9 Million CAD | -105.94% |
| 2020 Q4 | -21.9 Million CAD | -305.12% |
| 2020 Q3 | 10.68 Million CAD | -90.2% |
| 2020 Q1 | 373.36 Million CAD | 1.16% |
| 2019 FY | 369.06 Million CAD | -21.82% |
| 2019 Q2 | 445.78 Million CAD | -30.69% |
| 2019 Q1 | 643.2 Million CAD | 36.24% |
| 2019 Q3 | 362.5 Million CAD | -18.68% |
| 2019 Q4 | 369.06 Million CAD | 1.81% |
| 2018 Q3 | 292.43 Million CAD | -2.77% |
| 2018 Q1 | 143.3 Million CAD | 25.69% |
| 2018 FY | 472.09 Million CAD | 314.06% |
| 2018 Q2 | 300.78 Million CAD | 109.89% |
| 2018 Q4 | 472.09 Million CAD | 61.44% |
| 2017 Q4 | 114.01 Million CAD | 621.82% |
| 2017 FY | 114.01 Million CAD | 218.88% |
| 2017 Q3 | -21.85 Million CAD | 93.77% |
| 2017 Q2 | -350.52 Million CAD | -474.63% |
| 2017 Q1 | -61 Million CAD | 36.4% |
| 2016 Q4 | -95.9 Million CAD | -3.88% |
| 2016 Q1 | -9.66 Million CAD | -193.72% |
| 2016 Q2 | -35.22 Million CAD | -264.36% |
| 2016 Q3 | -92.32 Million CAD | -162.07% |
| 2016 FY | -95.9 Million CAD | -1029.63% |
| 2015 Q2 | 8.84 Million CAD | 2.7% |
| 2015 Q1 | 8.61 Million CAD | 6.95% |
| 2015 FY | 10.31 Million CAD | 28.09% |
| 2015 Q4 | 10.31 Million CAD | 8.09% |
| 2015 Q3 | 9.54 Million CAD | 7.89% |
| 2014 Q2 | 1.73 Million CAD | 241.96% |
| 2014 FY | 8.05 Million CAD | 2225.37% |
| 2014 Q4 | 8.05 Million CAD | 247.56% |
| 2014 Q3 | 2.31 Million CAD | 33.54% |
| 2014 Q1 | -1.22 Million CAD | -222.56% |
| 2013 Q4 | -378.98 Thousand CAD | 34.11% |
| 2013 FY | -378.98 Thousand CAD | 41.22% |
| 2013 Q3 | -575.13 Thousand CAD | -2.46% |
| 2013 Q2 | -561.29 Thousand CAD | 5.88% |
| 2013 Q1 | -596.35 Thousand CAD | 7.5% |
| 2012 Q3 | -734.57 Thousand CAD | 14.98% |
| 2012 Q2 | -864.03 Thousand CAD | 11.33% |
| 2012 Q1 | -974.46 Thousand CAD | 10.81% |
| 2012 FY | -644.71 Thousand CAD | 40.99% |
| 2012 Q4 | -644.71 Thousand CAD | 12.23% |
| 2011 Q4 | -1.09 Million CAD | 13.68% |
| 2011 Q3 | -1.26 Million CAD | -6630.68% |
| 2011 Q2 | -18.8 Thousand CAD | 34.15% |
| 2011 Q1 | -28.55 Thousand CAD | -33.15% |
| 2011 FY | -1.09 Million CAD | -4994.46% |
| 2010 Q1 | -35.58 Thousand CAD | 69.57% |
| 2010 Q3 | -55.41 Thousand CAD | 2.52% |
| 2010 Q4 | -21.44 Thousand CAD | 61.3% |
| 2010 FY | -21.44 Thousand CAD | 81.66% |
| 2010 Q2 | -56.84 Thousand CAD | -59.74% |
| 2009 FY | -116.92 Thousand CAD | 92.65% |
| 2009 Q3 | -9364.00 CAD | 99.46% |
| 2009 Q1 | -1.57 Million CAD | 0.85% |
| 2009 Q2 | -1.73 Million CAD | -9.95% |
| 2009 Q4 | -116.92 Thousand CAD | -1148.65% |
| 2008 Q2 | -1.61 Million CAD | 0.09% |
| 2008 Q4 | -1.59 Million CAD | 0.46% |
| 2008 FY | -1.59 Million CAD | 2.39% |
| 2008 Q1 | -1.62 Million CAD | 0.56% |
| 2008 Q3 | -1.59 Million CAD | 1.3% |
| 2007 Q2 | -1.67 Million CAD | -315.36% |
| 2007 Q1 | -403.72 Thousand CAD | 0.0% |
| 2007 FY | -1.63 Million CAD | -280.86% |
| 2007 Q4 | -1.63 Million CAD | 1.09% |
| 2007 Q3 | -1.64 Million CAD | 1.71% |
| 2006 FY | -428.06 Thousand CAD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Avicanna Inc. | 1.32 Million CAD | 752.089% |
| Avant Brands Inc. | 17.93 Million CAD | 148.232% |
| Cardiol Therapeutics Inc. | -34.77 Million CAD | 75.13% |
| Crescita Therapeutics Inc. | -8.13 Million CAD | -6.358% |
| Knight Therapeutics Inc. | 10.33 Million CAD | 183.717% |
| MediPharm Labs Corp. | -15.68 Million CAD | 44.868% |
| OrganiGram Holdings Inc. | -33.7 Million CAD | 74.345% |
| Canopy Growth Corporation | 512.87 Million CAD | 101.686% |
| Willow Biosciences Inc. | -989 Thousand CAD | -774.419% |
| Auxly Cannabis Group Inc. | 142.88 Million CAD | 106.053% |